BioCryst
is a North Carolina-based biotechnology company that researches and develops novel oral therapeutics for the treatment of HAE diseases... Read moreBioCryst
is a North Carolina-based biotechnology company that researches and develops novel oral therapeutics for the treatment of HAE diseases... Read more
1986
PublicNASDAQBCRX
News
Conference Presentation
Feb 17, 2026
Yahoo
BioCryst to Present at Upcoming Investor Conference
Leadership Change
Jan 27, 2026
biocryst.com
Charlie Gayer joined BioCryst as President & CEO
Regulatory
Dec 12, 2025
RTTNews
BioCryst's Orladeyo Oral Pellets Win FDA Nod For HAE Patients 2 To Under 12
Acquisition
Oct 14, 2025
GlobeNewswire
BioCryst acquired Astria Therapeutics, Inc. for $700M
BioCryst Competitors
1
2
3
4
5
6
7
8
9